Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1994 2
1996 4
1997 1
1998 3
1999 4
2000 2
2001 2
2002 4
2003 11
2004 4
2005 2
2006 12
2007 13
2008 18
2009 9
2010 13
2011 7
2012 9
2013 5
2014 9
2015 9
2016 15
2017 10
2018 19
2019 12
2020 14
2021 19
2022 12
2023 18
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

228 results

Results by year

Filters applied: . Clear all
Page 1
Hyperthermic intraperitoneal chemotherapy in colorectal cancer.
Fisher OM, Brown C, Esquivel J, Larsen SG, Liauw W, Alzahrani NA, Morris DL, Kepenekian V, Sourrouille I, Dumont F, Tuech JJ, Ceribelli C, Doussot B, Sgarbura O, Alhosni M, Quenet F, Glehen O, Cashin PH; Peritoneal Surface Oncology Group International (PSOGI), Nordic Peritoneal Oncology Group (NPOG), American Society for Peritoneal Surface Malignancy (ASPSM) and BIG-RENAPE Groups. Fisher OM, et al. BJS Open. 2024 May 8;8(3):zrae017. doi: 10.1093/bjsopen/zrae017. BJS Open. 2024. PMID: 38722737 Free PMC article.
Colorectal carcinoma peritoneal metastases-derived organoids: results and perspective of a model for tailoring hyperthermic intraperitoneal chemotherapy from bench-to-bedside.
Varinelli L, Battistessa D, Guaglio M, Zanutto S, Illescas O, Lorenc EJ, Pisati F, Kusamura S, Cattaneo L, Sabella G, Milione M, Perbellini A, Noci S, Paolino C, Khun E, Galassi M, Cavalleri T, Deraco M, Gariboldi M, Baratti D. Varinelli L, et al. J Exp Clin Cancer Res. 2024 May 2;43(1):132. doi: 10.1186/s13046-024-03052-5. J Exp Clin Cancer Res. 2024. PMID: 38698446 Free PMC article.
Prognostic value of specific KRAS mutations in patients with colorectal peritoneal metastases.
Tonello M, Baratti D, Sammartino P, Di Giorgio A, Robella M, Sassaroli C, Framarini M, Valle M, Macrì A, Graziosi L, Coccolini F, Lippolis PV, Gelmini R, Deraco M, Biacchi D, Aulicino M, Vaira M, De Franciscis S, D'Acapito F, Carboni F, Milone E, Donini A, Fugazzola P, Faviana P, Sorrentino L, Pizzolato E, Cenzi C, Del Bianco P, Sommariva A. Tonello M, et al. ESMO Open. 2024 Apr;9(4):102976. doi: 10.1016/j.esmoop.2024.102976. Epub 2024 Apr 12. ESMO Open. 2024. PMID: 38613907 Free PMC article.
External validation of COMPASS and BIOSCOPE prognostic scores in colorectal peritoneal metastases treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
Tonello M, Baratti D, Sammartino P, Di Giorgio A, Robella M, Sassaroli C, Framarini M, Valle M, Macrì A, Graziosi L, Fugazzola P, Lippolis PV, Gelmini R, Biacchi D, Kasamura S, Deraco M, Cenzi C, Del Bianco P, Vaira M, Sommariva A. Tonello M, et al. Eur J Surg Oncol. 2023 Mar;49(3):604-610. doi: 10.1016/j.ejso.2022.10.007. Epub 2022 Oct 22. Eur J Surg Oncol. 2023. PMID: 38432873
Is Systemic Chemotherapy Useful in Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Colorectal Peritoneal Metastases? A Propensity-Score Analysis.
Tonello M, Baratti D, Sammartino P, Di Giorgio A, Robella M, Sassaroli C, Framarini M, Valle M, Macrì A, Graziosi L, Coccolini F, Lippolis PV, Gelmini R, Deraco M, Biacchi D, Santullo F, Vaira M, Di Lauro K, D'Acapito F, Carboni F, Milone E, Donini A, Fugazzola P, Faviana P, Sorrentino L, Pizzolato E, Cenzi C, Del Bianco P, Sommariva A. Tonello M, et al. Ann Surg Oncol. 2024 Jan;31(1):594-604. doi: 10.1245/s10434-023-14417-z. Epub 2023 Oct 13. Ann Surg Oncol. 2024. PMID: 37831280
Mytomicin-C, Metronomic Capecitabine, and Bevacizumab in Patients With Unresectable or Relapsed Pseudomyxoma Peritonei of Appendiceal Origin.
Ghelardi F, Raimondi A, Morano F, Randon G, Pannone A, Guaglio M, Mazzoli G, Nasca V, Milione M, Leoncini G, Sabella G, Greco GF, Lampis BR, Galassi M, Delfanti S, Nannini M, Intini R, Baratti D, Di Bartolomeo M, Deraco M, Pietrantonio F. Ghelardi F, et al. Clin Colorectal Cancer. 2023 Dec;22(4):450-456.e1. doi: 10.1016/j.clcc.2023.08.005. Epub 2023 Aug 11. Clin Colorectal Cancer. 2023. PMID: 37657955
228 results